ESR1 and breast carcinoma: In contrast to CYP19A1 expression, we found no significant association of rs10046 genotypes with breast cancer prognosis in our analyses of the overall survival, disease-free survival, and metastasis-free survival in unselected, ER-positive, and ER-negative patients (Supplementary Figs. 2 and 3).